montelukast and Ecchymosis

montelukast has been researched along with Ecchymosis* in 1 studies

Other Studies

1 other study(ies) available for montelukast and Ecchymosis

Article	Year
A rare adverse effect of montelukast treatment: ecchymosis. Respiratory care, 2013, Volume: 58, Issue:9 Montelukast is a leukotriene receptor antagonist that is effective in the treatment of allergic rhinitis and asthma. We report a rare case of a 31-year-old woman with a history of allergic rhinitis and moderate persistent asthma, who experienced severe bruising on her lower extremities after starting montelukast treatment. Clinicians should be aware of the possibility of unusual bruising during montelukast therapy, and in those patients montelukast should be discontinued. Topics: Acetates; Adult; Cyclopropanes; Ecchymosis; Female; Humans; Leukotriene Antagonists; Lower Extremity; Quinolines; Rhinitis, Allergic, Seasonal; Sulfides	2013

Article

Year

A rare adverse effect of montelukast treatment: ecchymosis.

Respiratory care, 2013, Volume: 58, Issue:9

Montelukast is a leukotriene receptor antagonist that is effective in the treatment of allergic rhinitis and asthma. We report a rare case of a 31-year-old woman with a history of allergic rhinitis and moderate persistent asthma, who experienced severe bruising on her lower extremities after starting montelukast treatment. Clinicians should be aware of the possibility of unusual bruising during montelukast therapy, and in those patients montelukast should be discontinued.

Topics: Acetates; Adult; Cyclopropanes; Ecchymosis; Female; Humans; Leukotriene Antagonists; Lower Extremity; Quinolines; Rhinitis, Allergic, Seasonal; Sulfides

2013